Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple Follow-Up program keep HIV patients healthier after leaving the hospital?

NCT ID NCT06931431

Disease control Sponsor: University of North Carolina, Chapel Hill Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This study tests whether a structured transition-of-care program can improve support for adults in Malawi who are hospitalized with both HIV and a chronic condition like high blood pressure. The program includes discharge planning, nurse home visits within a week, and community follow-up. Researchers will measure how feasible and acceptable the program is for patients, caregivers, and health workers. The goal is to see if this approach can be successfully implemented in this setting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transition of Care Model (TCM) - a structured program involving discharge assessment, care planning, provider communication, and community-based follow-up visits
What this could lead to
If successful, this could establish a practical model to support adults with HIV and chronic conditions after hospital discharge, potentially reducing readmissions and improving health outcomes in low-resource settings.
What could go wrong
This is a small pilot study focused on feasibility, not effectiveness. The model may not be easily adaptable to the local context, and results may not generalize beyond the study setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

75 people

The number who actually took part.

Started

May 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years of age or older * living with HIV * admitted to internal medicine * has at least a cardiometabolic NCO as the primary or secondary reason for admission based on the HIV inpatient consultation Exclusion Criteria: * patients living beyond Lilongwe urban

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease Noncommunicable Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV Noncommunicable diseases

Contacts and locations

Locations

  • Kamuzu Central Hospital

    Lilongwe, Malawi

More trials for these conditions

Other studies related to the condition(s) this trial covers.